NURS 5432 Verified Multiple Choice and Conceptual
Actual Frequently Tested Exam Questions With
Reviewed 100% Correct Detailed Answers
Guaranteed Pass!!Current Update!!
1. Digital Breast Tomosynthesis - ANSWER provides 3D images from a
mammogram machine which rotates around the breast
2. Fibroadenoma - ANSWER a round, firm, rubbery mass that arises from
excess growth of glandular and connective tissue in the breast
Fluctuation in size with pregnancy or menstrual cycle
NO nipple discharge
lesions >5cm= giant fibroadenoma
3. Fibroadenoma Diagnosis and Treatment - ANSWER Diagnosis:
- Palpation
- Mammogram or MRI
- US to differentiate cyst from mass
- fine needle aspiration Bx
Treatment:
- Surgery
, 4. Fibrocystic breast disease "nodular sensitivie breast" - ANSWER the
presence of single or multiple benign cysts in the breasts
5. Mastoplasia - ANSWER thickening of breast tissue in a ropelike manner
that predominate during menstrual cycle
6. Non pharm management for fibrocystic BD - ANSWER Cold compress,
supportive bra 24 hours a day,
sodium restriction 10 days before onset of menstruation, decrease or eliminate
caffeine,
reduce dietary fat
7. Pharm management for fibrocystic BD - ANSWER vitaminD 2000 IU day
spironolactone for swelling (25-200mg PO daily; start with 100 IU daily)
vitamin E 200 IU twice daily or 500 IU daily
evening primrose oil 2-4g daily
oral contraceptives
8. Intraductal papilloma (IDP) - ANSWER Benign tumor within the ductile
system (ductal epithelium and myoepithelial cells) of the breast that may
occur alone or as multiple tumors. Most common in women ages 35 to 50
years. Ductal ectasia is often associated with IDP
9. For bilateral nipple discharge - ANSWER Check for TSH (hypothyroid),
prolactin (pituitary tumor)
,-medications: spironolactone, antihypertensives, antidepressants,
antidopaminergics, estrogen OCPs, opioids, marijuana, methyldopa, H2 receptor
antagonist
10. Breast cancer screening per ACS - ANSWER Anual between 45 and 54
years, then every two years after age 55
11. Breast Cancer - ANSWER 2nd most cause of CA death in USA women
Malignant neoplasm of cells native to breast epithelial, glandular, or stoma
12. Hormone replacement therapy is a RISK FACTOR for Breast CA - ANSWER
(combination estrogen-progestrone and estrogen only agent)
during perimenopause increases breast cancer risk for 10 years after medication
discontinued
13. Treatment for breast CA - ANSWER Hormonal therapy
-SERMS
Tamoxifen (20-40mg daily; if more than 20 use twice daily dose)
Raloxifene (60mg daily)
Calcium and vitamin D supplement is recommended
- non-steroidal aromatase inhibitors {lowers estrogen production}
Anastrozole 1mg daily
Letrozole 2.5mg daily
-chemotherapy
, -radiation therapy
14. Benign Ovarian Tumors - ANSWER Non-malignant tumor of the ovary
may be solid or cystic
diagnostic test; pregnancy test, urine analysis, tumor marker test that is CA125
<35 MCG/ML, transvaginal ultrasound or MRI. Treatments:
non-pharmacological- laparoscopic surgery.
Pharmacologic - oral contraceptives or estrogen therapy
15. Ovarian Cancer - ANSWER Malignancy of ovaries surface epithelium,
germ or stromal cells. Epitherlial ovarian cancer (EOC) is 90%
Prevention: use of oral contraceptives {5years decrease risk by 20%, 15 years
decrease risk by 50%}, multiparity, breastfeeding, tubal ligation or hysterectomy,
salpingo-oopherectomy, check CA125, transvaginal ultrasound q6-12 month at age
3- or 10 years prior to earliest age of family cancer diagnosis
Diagnostic:
CBC, LFT's to rule out hepatic disease, urinalysis, serum albumin, Tumor markers
{If epithelial tumor: CA-125, CA19-9, CEA, but CA125 might not be the best
accurate one. If nonepithelial tumors: inhibin A/B, HCG, AFP, LDH}, pelvic
(transvaginal) US, CT abdomen and pelvis with contrast, CXR or CT chest for
pleural effusion or lung nodules
Treatment:
Surgical and chemotherapy
Actual Frequently Tested Exam Questions With
Reviewed 100% Correct Detailed Answers
Guaranteed Pass!!Current Update!!
1. Digital Breast Tomosynthesis - ANSWER provides 3D images from a
mammogram machine which rotates around the breast
2. Fibroadenoma - ANSWER a round, firm, rubbery mass that arises from
excess growth of glandular and connective tissue in the breast
Fluctuation in size with pregnancy or menstrual cycle
NO nipple discharge
lesions >5cm= giant fibroadenoma
3. Fibroadenoma Diagnosis and Treatment - ANSWER Diagnosis:
- Palpation
- Mammogram or MRI
- US to differentiate cyst from mass
- fine needle aspiration Bx
Treatment:
- Surgery
, 4. Fibrocystic breast disease "nodular sensitivie breast" - ANSWER the
presence of single or multiple benign cysts in the breasts
5. Mastoplasia - ANSWER thickening of breast tissue in a ropelike manner
that predominate during menstrual cycle
6. Non pharm management for fibrocystic BD - ANSWER Cold compress,
supportive bra 24 hours a day,
sodium restriction 10 days before onset of menstruation, decrease or eliminate
caffeine,
reduce dietary fat
7. Pharm management for fibrocystic BD - ANSWER vitaminD 2000 IU day
spironolactone for swelling (25-200mg PO daily; start with 100 IU daily)
vitamin E 200 IU twice daily or 500 IU daily
evening primrose oil 2-4g daily
oral contraceptives
8. Intraductal papilloma (IDP) - ANSWER Benign tumor within the ductile
system (ductal epithelium and myoepithelial cells) of the breast that may
occur alone or as multiple tumors. Most common in women ages 35 to 50
years. Ductal ectasia is often associated with IDP
9. For bilateral nipple discharge - ANSWER Check for TSH (hypothyroid),
prolactin (pituitary tumor)
,-medications: spironolactone, antihypertensives, antidepressants,
antidopaminergics, estrogen OCPs, opioids, marijuana, methyldopa, H2 receptor
antagonist
10. Breast cancer screening per ACS - ANSWER Anual between 45 and 54
years, then every two years after age 55
11. Breast Cancer - ANSWER 2nd most cause of CA death in USA women
Malignant neoplasm of cells native to breast epithelial, glandular, or stoma
12. Hormone replacement therapy is a RISK FACTOR for Breast CA - ANSWER
(combination estrogen-progestrone and estrogen only agent)
during perimenopause increases breast cancer risk for 10 years after medication
discontinued
13. Treatment for breast CA - ANSWER Hormonal therapy
-SERMS
Tamoxifen (20-40mg daily; if more than 20 use twice daily dose)
Raloxifene (60mg daily)
Calcium and vitamin D supplement is recommended
- non-steroidal aromatase inhibitors {lowers estrogen production}
Anastrozole 1mg daily
Letrozole 2.5mg daily
-chemotherapy
, -radiation therapy
14. Benign Ovarian Tumors - ANSWER Non-malignant tumor of the ovary
may be solid or cystic
diagnostic test; pregnancy test, urine analysis, tumor marker test that is CA125
<35 MCG/ML, transvaginal ultrasound or MRI. Treatments:
non-pharmacological- laparoscopic surgery.
Pharmacologic - oral contraceptives or estrogen therapy
15. Ovarian Cancer - ANSWER Malignancy of ovaries surface epithelium,
germ or stromal cells. Epitherlial ovarian cancer (EOC) is 90%
Prevention: use of oral contraceptives {5years decrease risk by 20%, 15 years
decrease risk by 50%}, multiparity, breastfeeding, tubal ligation or hysterectomy,
salpingo-oopherectomy, check CA125, transvaginal ultrasound q6-12 month at age
3- or 10 years prior to earliest age of family cancer diagnosis
Diagnostic:
CBC, LFT's to rule out hepatic disease, urinalysis, serum albumin, Tumor markers
{If epithelial tumor: CA-125, CA19-9, CEA, but CA125 might not be the best
accurate one. If nonepithelial tumors: inhibin A/B, HCG, AFP, LDH}, pelvic
(transvaginal) US, CT abdomen and pelvis with contrast, CXR or CT chest for
pleural effusion or lung nodules
Treatment:
Surgical and chemotherapy
